AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Gliclashield-M 40 Tablet

Prescription Icon
Prescription Required

Marketer

Shield & Care Pharmaceuticals Pvt Ltd

Salt Composition

Gliclazide (40mg) + Metformin (500mg)

Overview Gliclashield-M 40 Tablet

DiaBeta-Duo 40mg tablets are classified as antidiabetic medications, combining two active ingredients for managing type 2 diabetes in adults. This medication helps regulate blood glucose levels. DiaBeta-Duo 40mg should be administered with food, consistently at the same time daily for optimal effectiveness. Dosage will be determined by your physician and may be adjusted based on your blood sugar readings. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical supervision can lead to elevated glucose, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan including diet, exercise, and weight management as recommended by your doctor. Lifestyle choices significantly impact diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation, and vomiting. Always carry a rapid-acting glucose source (e.g., sugary snacks, juice) to counter hypoglycemia. Alcohol consumption should be limited due to its potential to lower blood sugar. Additional side effects may include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is a possibility. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your doctor before commencing treatment. Consult your physician before using this medication during pregnancy or breastfeeding. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are necessary.

Uses of Gliclashield-M 40 Tablet

Adult-onset diabetes

Major Benefits of Gliclashield-M 40 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Gliclashield-M 40 Tablet whole; do not crush, chew, or divide it. Administer this medicine with food.

Common Side effects of Gliclashield-M 40 Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Gliclashield-M 40 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Gliclashield-M 40 Tablets should be administered with a meal.

How Gliclashield-M 40 Tablet works:

Gliclazide and metformin, combined in Gliclashield-M 40 Tablet, offer dual-action diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Gliclashield-M 40 Tablet and alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Gliclashield-M 40 Tablet during pregnancy is contraindicated due to confirmed risks to fetal development. Nevertheless, a physician might exceptionally prescribe it in emergencies where the potential benefits outweigh the hazards. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Gliclashield-M 40 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Gliclashield-M 40 Tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Gliclashield-M 40 Tablets. Physician consultation is recommended. Regular monitoring of kidney function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Gliclashield-M 40 Tablet cautiously, potentially requiring dosage modification. A physician's consultation is advised. In those with mild to moderate liver disease, initiation should be at a low dose; Gliclashield-M 40 Tablet is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Gliclashield-M 40 Tablet :

Should you forget to take a Gliclashield-M 40 Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Gliclashield-M 40 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Gliclashield-M 40 Tablet

Gliclashield-M 40 Tablet combines gliclazide and metformin to manage type 2 diabetes mellitus in adults. It improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This combination is unsuitable for type 1 diabetes.
Gliclashield-M 40 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Gliclashield-M 40 Tablets can cause low blood sugar (hypoglycemia), leading to symptoms like nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other diabetes medications are used concurrently. Regular blood sugar monitoring is crucial. Always carry glucose tablets, honey, or fruit juice.
Gliclashield-M 40 Tablet can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-Associated Lactic Acidosis or MALA). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Gliclashield-M 40 Tablet and seek immediate medical attention.
Prolonged Gliclashield-M 40 Tablet use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and ataxia), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Gliclashield-M 40 Tablets are contraindicated in patients with allergies to any ingredient or excipient. They should also not be used by those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Gliclashield-M 40 Tablet and alcohol is unsafe. This combination can worsen low blood sugar and raise the risk of lactic acidosis.
Gliclashield-M 40 Tablet combines gliclazide and metformin to manage type 2 diabetes mellitus (DM) in adults. It enhances blood glucose control when used with a healthy diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 DM.
Gliclashield-M 40 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Gliclashield-M 40 Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Gliclashield-M 40 Tablet can cause lactic acidosis, a serious, potentially life-threatening condition characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis, or MALA). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Gliclashield-M 40 Tablet and seek immediate medical attention.
Prolonged Gliclashield-M 40 Tablet use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Gliclashield-M 40 Tablets are contraindicated in patients with allergies to any ingredient or excipient, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining Gliclashield-M 40 tablets and alcohol is unsafe. This combination can worsen low blood sugar and raise the risk of lactic acidosis.
Gliclashield-M 40 Tablet
82
MRP 101
18% off